Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Conference Correspondent
Results from the ARCHER 1009 Study: Dacomitinib Versus Erlotinib for Second-/Third-Line Therapy of Locally Advanced or Metastatic NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
— June 2, 2014
Read Article
Results from PROFILE 1014: First-Line Crizotinib Versus Pemetrexed-Platinum in ALK+ NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
— June 2, 2014
Read Article
Erlotinib Plus Bevacizumab as First-Line Treatment for EGFR+, Advanced NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
— June 2, 2014
Read Article
Adjuvant Ipilimumab for Patients with High-Risk Melanoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
— June 2, 2014
Read Article
First Trial Assessing Nivolumab in Platinum-Resistant Ovarian Cancer
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
— June 1, 2014
Read Article
Phase 2 Trial of Nivolumab in Metastatic Renal Cell Carcinoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
— June 1, 2014
Read Article
Phase 2 Trial of Nivolumab and VEGF Inhibitors in First-Line Metastatic Renal Cell Carcinoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
— June 1, 2014
Read Article
MPDL3280A, an Anti-PD-L1 Monoclonal Antibody, in Metastatic Bladder Cancer
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
— June 1, 2014
Read Article
Chemotherapy Plus Bevacizumab or Cetuximab in mCRC
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
— June 1, 2014
Read Article
Racial Differences in KRAS/BRAF Mutation Rates and Survival in mCRC
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
— June 1, 2014
Read Article
Page 40 of 44
37
38
39
40
41
42
43
Top Trending Articles
1.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
2.
HOPA Highlights: What's New in 2025?
3.
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma